The erectile dysfunction devices market has seen considerable growth due to a variety of factors.
• The erectile dysfunction devices market has experienced rapid growth in recent years. It will increase from $1.87 billion in 2024 to $2.11 billion in 2025, at a CAGR of 12.9%.
The growth can be attributed to greater awareness of erectile dysfunction, higher acceptance of treatment options, an aging population, the prevalence of chronic conditions, and improvements in device safety and efficacy.
The erectile dysfunction devices market is expected to maintain its strong growth trajectory in upcoming years.
• The erectile dysfunction devices market is projected to grow quickly, reaching $3.39 billion by 2029 with a CAGR of 12.6%.
This growth is driven by the increasing prevalence of erectile dysfunction, personalized treatment options, the growth of telemedicine, supportive healthcare policies, and a rise in non-invasive treatments. Key trends include smart devices with integrated monitoring, minimally invasive treatments, home-based options, advancements in biocompatible materials, and AI integration for personalized care.
The increasing prevalence of prostate cancer is expected to propel the growth of the erectile dysfunction devices market. Prostate cancer affects the prostate gland and is linked to aging, better detection, and lifestyle changes. Erectile dysfunction devices help patients improve sexual function after cancer treatment. In January 2024, Cancer Australia estimated that 24,217 new cases would be diagnosed in 2022, and the risk of diagnosis by age 85 is 1 in 6, underlining the market’s growth potential.
The erectile dysfunction devices market covered in this report is segmented –
1) By Device Type: Non-Surgical Devices, Surgical Devices
2) By Cause: Diabetes, Neurological Disorders, Hypertension, Other Causes
3) By Approach: Invasive, Non-Invasive
4) By Age Group: Less Than 40 Years, 40-60 Years, More Than 60 Years
5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Non-Surgical Devices: Penile Pumps (Vacuum Erection Devices), External Penile Prostheses, Erectile Dysfunction Medications (Oral, Topical), Penile Traction Devices, Intraurethral Suppositories
2) By Surgical Devices: Penile Implants (Inflatable, Semi-Rigid), Penile Prostheses (Inflatable, Non-Inflatable), Vascular Surgery Devices (Penile Artery Surgery)
Companies in the erectile dysfunction devices market are focusing on non-invasive technologies to improve user experience and gain a competitive edge. Non-invasive devices enhance erectile function without surgery, using techniques like vacuum therapy or electrical stimulation. For instance, in June 2024, Ohh-Med Medical launched VerticaPlus, a device for erectile dysfunction. It features a cloud-based app offering real-time feedback, step-by-step tutorials, and custom settings for precise therapy, improving the treatment experience.
Major companies operating in the erectile dysfunction devices market are:
• Boston Scientific Corporation
• Medline Industries LP
• Coloplast Corporation
• Hollister Incorporated
• MTS Medical AG
• Alma Lasers Ltd.
• Owen Mumford Ltd.
• Shenzhen Huikang Medical Apparatus Co. Ltd.
• Storz Medical AG
• UroMatrix Medical Systems
• Medispec Ltd.
• Zephyr Surgical Implants
• Timm Medical Technologies Inc.
• Promedon GmbH
• Zimmer MedizinSysteme GmbH
• Mercury Healthcare Pvt. Ltd.
• Rigicon Inc.
• NOVAmedtek
• Tyna International Ltd.
• Vacurect
• The Elator
• Pos-T-Vac Medical Inc.
• Silimed Indústria de Implantes
North America was the largest region in the erectile dysfunction devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the erectile dysfunction devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.